Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Intra-aortic balloon counterpulsation for acute decompensated heart failure.

Mizuno M, Sato N, Kajimoto K, Sakata Y, Minami Y, Munakata R, Hagiwara N, Takano T; Acute Decompensated Heart Failure Syndromes [ATTEND] investigators.

Int J Cardiol. 2014 Oct 20;176(3):1444-6. doi: 10.1016/j.ijcard.2014.08.154. Epub 2014 Sep 2. No abstract available.

PMID:
25223815
2.

Prognostic impact of renal dysfunction does not differ according to the clinical profiles of patients: insight from the acute decompensated heart failure syndromes (ATTEND) registry.

Inohara T, Kohsaka S, Sato N, Kajimoto K, Keida T, Mizuno M, Takano T; ATTEND Investigators.

PLoS One. 2014 Sep 8;9(9):e105596. doi: 10.1371/journal.pone.0105596. eCollection 2014.

3.

Associations of anemia and renal dysfunction with outcomes among patients hospitalized for acute decompensated heart failure with preserved or reduced ejection fraction.

Kajimoto K, Sato N, Keida T, Sakata Y, Takano T; Acute Decompensated Heart Failure Syndromes (ATTEND) Investigators.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1912-21. doi: 10.2215/CJN.04400514. Epub 2014 Sep 2.

PMID:
25183660
4.

Low admission heart rate is a marker rather than a mediator of increased in-hospital mortality for patients with acute heart failure syndromes in sinus rhythm.

Kajimoto K, Sato N, Keida T, Sakata Y, Asai K, Mizuno M, Takano T; investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry.

Int J Cardiol. 2014 Jan 15;171(1):98-100. doi: 10.1016/j.ijcard.2013.11.087. Epub 2013 Dec 4. No abstract available.

PMID:
24342405
5.

Relationship between systolic blood pressure and preserved or reduced ejection fraction at admission in patients hospitalized for acute heart failure syndromes.

Kajimoto K, Sato N, Sakata Y, Takano T; Acute Decompensated Heart Failure Syndromes (ATTEND) investigators.

Int J Cardiol. 2013 Oct 12;168(5):4790-5. doi: 10.1016/j.ijcard.2013.07.226. Epub 2013 Aug 1.

PMID:
23962780
6.

Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry).

Sato N, Gheorghiade M, Kajimoto K, Munakata R, Minami Y, Mizuno M, Aokage T, Asai K, Sakata Y, Yumino D, Mizuno K, Takano T; ATTEND Investigators.

Am J Cardiol. 2013 Apr 1;111(7):1019-25. doi: 10.1016/j.amjcard.2012.12.019. Epub 2013 Jan 9.

PMID:
23312128
7.

The SNP in the promoter region of the bovine ELOVL5 gene influences economic traits including subcutaneous fat thickness.

Matsumoto H, Shimizu Y, Tanaka A, Nogi T, Tabuchi I, Oyama K, Taniguchi M, Mannen H, Sasazaki S.

Mol Biol Rep. 2013 Apr;40(4):3231-7. doi: 10.1007/s11033-012-2398-x. Epub 2012 Dec 27.

PMID:
23269620
8.

The impairment of endocardial radial strain is related to aortic stenosis severity in patients with aortic stenosis and preserved LV ejection fraction using two-dimensional speckle tracking echocardiography.

Ohara Y, Fukuoka Y, Tabuchi I, Sahara S, Hosogi S, Nishimoto M, Yamamoto K.

Echocardiography. 2012 Nov;29(10):1172-80. doi: 10.1111/j.1540-8175.2012.01783.x. Epub 2012 Sep 11.

PMID:
22963344
9.

Comparison of two-dimensional and real-time three-dimensional transesophageal echocardiography in the assessment of aortic valve area.

Furukawa A, Abe Y, Tanaka C, Ito K, Tabuchi I, Osawa K, Kino N, Nakagawa E, Komatsu R, Haze K, Yoshiyama M, Yoshikawa J, Naruko T, Itoh A.

J Cardiol. 2012 May;59(3):337-43. doi: 10.1016/j.jjcc.2012.01.011. Epub 2012 Mar 7.

10.

Multi-line split DNA synthesis: a novel combinatorial method to make high quality peptide libraries.

Tabuchi I, Soramoto S, Ueno S, Husimi Y.

BMC Biotechnol. 2004 Sep 1;4:19.

11.

[In vitro virus in evolutionary molecular engineering].

Husimi Y, Tabuchi I.

Tanpakushitsu Kakusan Koso. 2003 Aug;48(11 Suppl):1481-7. Review. Japanese. No abstract available.

PMID:
12931603
12.

An Efficient Ligation Method in the Making of an in vitro Virus for in vitro Protein Evolution.

Tabuchi I, Soramoto S, Suzuki M, Nishigaki K, Nemoto N, Husimi Y.

Biol Proced Online. 2002 Oct 28;4:49-54.

13.

Next-generation protein-handling method: puromycin analogue technology.

Tabuchi I.

Biochem Biophys Res Commun. 2003 May 23;305(1):1-5.

PMID:
12732187
14.

Correlated flexible molecular coding and molecular evolvability.

Husimi Y, Aita T, Tabuchi I.

J Biol Phys. 2002 Sep;28(3):499-507. doi: 10.1023/A:1020305815106.

15.

An in vitro DNA virus for in vitro protein evolution.

Tabuchi I, Soramoto S, Nemoto N, Husimi Y.

FEBS Lett. 2001 Nov 23;508(3):309-12.

16.

[Augmenting effect of N-acetylglucosamine on ovulation induced by PMS-gonadotropin in rats].

Abe T, Tabuchi I, Shita H.

Horumon To Rinsho. 1967 Nov;15(11):907-10. Japanese. No abstract available.

PMID:
5628265
17.

[STUDIES ON AN EXAMINATION OF THE SEX CENTER BY EXAMINING THE BASOPHILS OF THE PERIPHERAL BLOOD].

TABUCHI I.

Nihon Sanka Fujinka Gakkai Zasshi. 1963 Nov;15:1247-55. Japanese. No abstract available.

PMID:
14096733
18.

Studies on the diagnosis of dysfunction in the hypothalamus-hypophysis-ovary-uterus system.

SUZUKI M, TAKAHASHI K, ABE T, TABUCHI I, YAMADA K.

Tohoku J Exp Med. 1962 Apr 25;76:251-66. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk